Q4 2024 Earnings Call Transcript March 12, 2025 Nektar Therapeutics misses on earnings expectations. Reported EPS is $-0.15 EPS, expectations were $-0.13. Operator: Good day, and thank you for ...

In today's edition of The Capitals, read about the narrow majority in the Dutch parliament calling on the Prime Minister to ...

This week we profile Stefan Babatchev, chief project engineer at Condra Cranes & Hoists, a manufacturer of cranes, hoists and material handling equipment ...